• 1
    Hameed M, Dorfman H. 2011. Primary malignant bone tumors–recent developments. Semin Diagn Pathol 28:86101.
  • 2
    Kim MJ, Cho KJ, Ayala AG, et al. 2011. Chondrosarcoma: with updates on molecular genetics. Sarcoma 2011:405437.
  • 3
    Moussavi-Harami F, Mollano A, Martin JA, et al. 2006. Intrinsic radiation resistance in human chondrosarcoma cells. Biochem Biophys Res Commun 346:379385.
  • 4
    Donati D, El Ghoneimy A, Bertoni F, et al. 2005. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br 87:15271530.
  • 5
    Lee FY, Mankin HJ, Fondren G, et al. 1999. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81:326338.
  • 6
    Pring ME, Weber KL, Unni KK, et al. 2001. Chondrosarcoma of the pelvis. A review of sixty-four cases. J Bone Joint Surg Am 83-A:16301642.
  • 7
    Sheth DS, Yasko AW, Johnson ME, et al. 1996. Chondrosarcoma of the pelvis. Prognostic factors for 67 patients treated with definitive surgery. Cancer 78:745750.
  • 8
    Pritchard DJ, Lunke RJ, Taylor WF, et al. 1980. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 45:149157.
  • 9
    Wirbel RJ, Schulte M, Maier B, et al. 2000. Chondrosarcoma of the pelvis: oncologic and functional outcome. Sarcoma 4:161168.
  • 10
    Teitelbaum SL. 2007. Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427435.
  • 11
    Hamm CA, Stevens JW, Xie H, et al. 2010. Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors. BMC Cancer 10:471.
  • 12
    Breitkreutz D, Diaz de Leon L, Paglia L, et al. 1979. Histological and biochemical studies of a transplantable rat chondrosarcoma. Cancer Res 39:50935100.
  • 13
    Gouin F, Ory B, Redini F, et al. 2006. Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival. Int J Cancer 119:980984.
  • 14
    Van Wesenbeeck L, Odgren PR, MacKay CA, et al. 2002. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci U S A 99:1430314308.
  • 15
    Morcuende JA, Stevens JW, Scheetz TE, et al. 2012. Swarm rat chondrosarcoma cells as an in vivo model: lung colonization and effects of tissue environment on tumor growth. Iowa Orthop J 32:4653.
  • 16
    Kenan S, Steiner GC. 1991. Experimental transplantation of the Swarm rat chondrosarcoma into bone: radiological and pathological studies. J Orthop Res 9:445451.
  • 17
    Gnant M, Mlineritsch B, Schippinger W, et al. 2009. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 360:679691.
  • 18
    Wardley A, Davidson N, Barrett-Lee P, et al. 2005. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. Br J Cancer 92:18691876.
  • 19
    Grimaud E, Damiens C, Rousselle AV, et al. 2002. Bone remodelling and tumour grade modifications induced by interactions between bone and swarm rat chondrosarcoma. Histol Histopathol 17:11031111.
  • 20
    Hascall GK, Kimura JH. 1981. The ultrastructure of cultures from the Swarm rat chondrosarcoma. Anat Rec 200:287292.
  • 21
    Kimura JH, Hardingham TE, Hascall VC, et al. 1979. Biosynthesis of proteoglycans and their assembly into aggregates in cultures of chondrocytes from the Swarm rat chondrosarcoma. J Biol Chem 254:26002609.
  • 22
    Maibenco HC, Krehbiel RH, Nelson D. 1967. Transplantable osteogenic tumor in the rat. Cancer Res 27:362366.
  • 23
    Murphey MD, Walker EA, Wilson AJ, et al. 2003. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics 23:12451278.
  • 24
    David E, Blanchard F, Heymann MF, et al. 2011. The bone niche of chondrosarcoma: a sanctuary for drug resistance, tumour growth and also a source of new therapeutic targets. Sarcoma 2011: 932451. 18.
  • 25
    Ebetino FH, Hogan AM, Sun S, et al. 2011. The relationship between the chemistry and biological activity of the bisphosphonates. Bone 49: 2033.
  • 26
    Suva LJ, Washam C, Nicholas RW, et al. 2011. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol 7:208218.
  • 27
    Oji GS, Gomez P, Kurriger G, et al. 2007. Indian hedgehog signaling pathway differences between swarm rat chondrosarcoma and native rat chondrocytes. Iowa Orthop J 27:916.
  • 28
    Miot-Noirault E, David E, Vidal A, et al. 2013. 99mTc-NT P 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model. EJNMMI Res 3:40.